Organon Canada Revenue and Competitors
Estimated Revenue & Valuation
- Organon Canada's estimated annual revenue is currently $24.5M per year.
- Organon Canada's estimated revenue per employee is $202,661
Employee Data
- Organon Canada has 121 Employees.
- Organon Canada grew their employee count by 20% last year.
Organon Canada's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Quality Canada | Reveal Email/Phone |
2 | Associate Director, Market Access & Policy | Reveal Email/Phone |
3 | Associate Director - Tax & Treasury | Reveal Email/Phone |
4 | Associate Director - Marketing, Women's Health & Established Brands | Reveal Email/Phone |
5 | Executive Director & Business Unit Lead - Biosimilars | Reveal Email/Phone |
6 | Associate Director, Policy & Access | Reveal Email/Phone |
7 | Associate Director Regulatory Affairs | Reveal Email/Phone |
8 | Associate Director – Marketing, Biosimilars | Reveal Email/Phone |
9 | Director Strategy & Operation Patient support program | Reveal Email/Phone |
10 | Associate Director, Pharmacovigilance at Organon Canada | Reveal Email/Phone |
Organon Canada Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.2M | 11 | -27% | N/A | N/A |
#2 | $30.2M | 88 | -29% | N/A | N/A |
#3 | N/A | 15 | 50% | N/A | N/A |
#4 | $10.7M | 100 | 5% | $39.7M | N/A |
#5 | $104.3M | 228 | 45% | N/A | N/A |
#6 | $47.8M | 238 | N/A | N/A | N/A |
#7 | $15.5M | 77 | 5% | N/A | N/A |
#8 | $395.8M | 1969 | 7% | N/A | N/A |
#9 | $187.3M | 831 | 8% | N/A | N/A |
#10 | $361.6M | 1799 | 6% | N/A | N/A |
What Is Organon Canada?
Organon is a new global health company with a singular vision: to make a better and healthier every day for every woman. As the only company of its size focused on women’s health, Organon puts women at the center of everything it does, launching with a commitment to listen to women to hear —and understand —her unmet health needs and help identify solutions that are urgently needed. Organon Canada will focus on medicines that support women’s health, including contraception, fertility, and hormone therapy, and as well as medicines to treat diseases that disproportionately affect women, such as rheumatoid arthritis. Its portfolio includes over 40 medicines and products across three lines of business: Women’s Health, Biosimilars and Established Brands. Organon est une nouvelle entreprise mondiale de santé dotée d'une vision unique : faire en sorte que chaque jour soit meilleur et plus sain pour chaque femme. Seule entreprise de cette taille à se consacrer à la santé des femmes, Organon place les femmes au centre de tout ce qu'elle entreprend, en s'engageant à écouter les femmes pour connaître - et comprendre - leurs besoins de santé non comblés et aider à identifier les solutions qui s'imposent de toute urgence. Organon Canada se focalisera sur les médicaments qui soutiennent la santé des femmes, y compris la contraception, la fertilité et l'hormonothérapie, ainsi que sur les médicaments pour traiter les maladies qui affectent les femmes de manière disproportionnée, comme la polyarthrite rhumatoïde. Son portfolio comprend plus de 40 médicaments et produits répartis sur trois lignes d'activité : santé des femmes, biosimilaires et marques établies.
keywords:N/AN/A
Total Funding
121
Number of Employees
$24.5M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Organon Canada News
... MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon has a portfolio...
"Organon will bring its commercial expertise to this ... Rahway, NJ, USA, (NYSE: MRK) known as MSD outside of the United States and Canada,...
Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.3M | 123 | -2% | N/A |
#2 | $12.9M | 123 | 23% | $3.8M |
#3 | $41.4M | 124 | 6% | N/A |
#4 | $46.6M | 127 | 4% | N/A |
#5 | $21.1M | 128 | 32% | N/A |